Search for a command to run...
Ticker: HINOON • | Sector: PHARMACEUTICALS
RevRevenue
✓ GoodRs. 23.20 B
ProfitNet Profit
✓ GoodRs. 3.25 B
EPSEPS
✓ Good₨61.41
ROEROE
~ Average8.5%
P/EP/E
~ Average15.0x
YieldDividend Yield
✓ Good4.0%
Highnoon Laboratories Limited has shown positive revenue growth of 19.4% over the past year. Net income has grown by 35.4% year-over-year. The company maintains a return on equity of 8.5%.
Company profile
HINOON • PHARMACEUTICALS
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. The registered office of the Company is situated at 17.5 km, Multan Road, Lahore.
HINOON stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.